198 related articles for article (PubMed ID: 17308274)
1. Cyclin D1 guanine/adenine 870 polymorphism with altered protein expression is associated with genomic instability and aggressive clinical biology of esophageal adenocarcinoma.
Izzo JG; Wu TT; Wu X; Ensor J; Luthra R; Pan J; Correa A; Swisher SG; Chao CK; Hittelman WN; Ajani JA
J Clin Oncol; 2007 Feb; 25(6):698-707. PubMed ID: 17308274
[TBL] [Abstract][Full Text] [Related]
2. Impact of cyclin D1 A870G polymorphism in esophageal adenocarcinoma tumorigenesis.
Izzo JG; Malhotra U; Wu TT; Ensor J; Babenko IM; Swisher SG; Correa A; Bresalier RS; Hittelman WN; Ajani JA
Semin Oncol; 2005 Dec; 32(6 Suppl 9):S11-5. PubMed ID: 16399423
[TBL] [Abstract][Full Text] [Related]
3. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
4. The molecular biology of esophageal adenocarcinoma.
Koppert LB; Wijnhoven BP; van Dekken H; Tilanus HW; Dinjens WN
J Surg Oncol; 2005 Dec; 92(3):169-90. PubMed ID: 16299787
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 and bax influence the prognosis after pancreatoduodenectomy for periampullary adenocarcinoma.
Tomazic A; Pegan V; Ferlan-Marolt K; Pleskovic A; Luzar B
Hepatogastroenterology; 2004; 51(60):1832-7. PubMed ID: 15532837
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D1 polymorphism (G870A) and risk for esophageal adenocarcinoma.
Casson AG; Zheng Z; Evans SC; Geldenhuys L; van Zanten SV; Veugelers PJ; Porter GA; Guernsey DL
Cancer; 2005 Aug; 104(4):730-9. PubMed ID: 15971196
[TBL] [Abstract][Full Text] [Related]
7. Genes of the interleukin-18 pathway are associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma.
Babar M; Ryan AW; Anderson LA; Segurado R; Turner G; Murray LJ; Murphy SJ; Johnston BT; Comber H; Reynolds JV; McManus R
Am J Gastroenterol; 2012 Sep; 107(9):1331-41. PubMed ID: 22664470
[TBL] [Abstract][Full Text] [Related]
8. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
9. Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation.
Wongsurawat VJ; Finley JC; Galipeau PC; Sanchez CA; Maley CC; Li X; Blount PL; Odze RD; Rabinovitch PS; Reid BJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):509-16. PubMed ID: 16537709
[TBL] [Abstract][Full Text] [Related]
10. Clinical biology of esophageal adenocarcinoma after surgery is influenced by nuclear factor-kappaB expression.
Izzo JG; Malhotra U; Wu TT; Luthra R; Correa AM; Swisher SG; Hofstetter W; Chao KS; Hung MC; Ajani JA
Cancer Epidemiol Biomarkers Prev; 2007 Jun; 16(6):1200-5. PubMed ID: 17548685
[TBL] [Abstract][Full Text] [Related]
11. COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.
Moons LM; Kuipers EJ; Rygiel AM; Groothuismink AZ; Geldof H; Bode WA; Krishnadath KK; Bergman JJ; van Vliet AH; Siersema PD; Kusters JG
Am J Gastroenterol; 2007 Nov; 102(11):2373-9. PubMed ID: 17581270
[TBL] [Abstract][Full Text] [Related]
12. Aberrant nuclear localization of beta-catenin without genetic alterations in beta-catenin or Axin genes in esophageal cancer.
Kudo J; Nishiwaki T; Haruki N; Ishiguro H; Shibata Y; Terashita Y; Sugiura H; Shinoda N; Kimura M; Kuwabara Y; Fujii Y
World J Surg Oncol; 2007 Feb; 5():21. PubMed ID: 17309796
[TBL] [Abstract][Full Text] [Related]
13. NcoI TNF-β gene polymorphism and TNF expression are associated with an increased risk of developing Barrett's esophagus and esophageal adenocarcinoma.
Menke V; van Zoest KP; Moons LM; Hansen B; Pot RG; Siersema PD; Kusters JG; Kuipers EJ
Scand J Gastroenterol; 2012 Apr; 47(4):378-86. PubMed ID: 22243485
[TBL] [Abstract][Full Text] [Related]
14. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analysis of surveillance biopsy samples from Barrett's mucosa--significance of sampling.
Werther M; Saure C; Pahl R; Schorr F; Rüschoff J; Alles JU; Heinmöller E
Pathol Res Pract; 2008; 204(5):285-94. PubMed ID: 18337019
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability.
Lung JC; Chu JS; Yu JC; Yue CT; Lo YL; Shen CY; Wu CW
Genes Chromosomes Cancer; 2002 Jul; 34(3):276-84. PubMed ID: 12007188
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical analysis with multiple antibodies in search of prognostic markers for clear cell renal cell carcinoma.
Phuoc NB; Ehara H; Gotoh T; Nakano M; Yokoi S; Deguchi T; Hirose Y
Urology; 2007 May; 69(5):843-8. PubMed ID: 17482919
[TBL] [Abstract][Full Text] [Related]
18. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?
Eloubeidi MA; Mason AC; Desmond RA; El-Serag HB
Am J Gastroenterol; 2003 Jul; 98(7):1627-33. PubMed ID: 12873590
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the CCND1 and HER-2/neu (ERBB2) proteins in esophageal and gastric cancers.
Bizari L; Borim AA; Leite KR; Gonçalves Fde T; Cury PM; Tajara EH; Silva AE
Cancer Genet Cytogenet; 2006 Feb; 165(1):41-50. PubMed ID: 16490596
[TBL] [Abstract][Full Text] [Related]
20. Expression of epidermal growth factor receptor and cyclin D1 in pretreatment biopsies as a predictive factor of radiotherapy efficacy in early glottic cancer.
Chang AR; Wu HG; Park CI; Jun YK; Kim CW
Head Neck; 2008 Jul; 30(7):852-7. PubMed ID: 18302259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
